Preliminary results from TRITON2: A phase II study of rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination repair (HRR) gene alterations
Autor: | Raymond S. McDermott, Daniel P. Petrylak, Jeremy Shapiro, M. Collins, T. Stanton, Simon Chowdhury, Howard I. Scher, Charles J. Ryan, N. J. Vogelzang, I. Percent, Alan H. Bryce, Arif Hussain, Andrew Simmons, R. J. Amato, Amita Patnaik, Wassim Abida, Joshua Zhang, Darrin Despain, T. Golsorskhi |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Brachial Plexus Neuritis business.industry Phases of clinical research Hematology Castration resistant medicine.disease 03 medical and health sciences Prostate cancer chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine Oncology chemistry 030220 oncology & carcinogenesis medicine Cancer research In patient Homologous recombination Rucaparib business Gene |
Zdroj: | Annals of Oncology. 29:viii272 |
ISSN: | 0923-7534 |
Databáze: | OpenAIRE |
Externí odkaz: |